Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Wallendszus, K"'
Autor:
Group, Ascend Study Collaborative, Bowman, L, Mafham, M, Wallendszus, K, Stevens, W, Buck, G, Barton, J, Murphy, K, Aung, T, Haynes, R, Cox, J, Murawska, A, Young, A, Lay, M, Chen, F, Sammons, E, Waters, E, Adler, A, Bodansky, J, Farmer, A, McPherson, R, Neil, A, Simpson, D, Peto, R, Baigent, C, Collins, R, Parish, S, Armitage, J
Background Increased intake of n-3 fatty acids has been associated with a reduced risk of cardiovascular disease in observational studies, but this finding has not been confirmed in randomized trials. It remains unclear whether n-3 (also called omega
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f48c6a1c0948b7ae1f77489c834f7f6
https://doi.org/10.1056/nejmoa1804989
https://doi.org/10.1056/nejmoa1804989
Autor:
KEECH, A. C., ARMITAGE, J. M., WALLENDSZUS, K. R., LAWSON, A., HAUER, A. J., PARISH, S. E., COLLINS for the Oxford Cholesterol Study Group, R.
1. It has been suggested that lipophilic HMG CoA reductase inhibitors, like lovastatin and simvastatin, may cause sleep disturbance. 2. Six hundred and twenty-one patients at increased risk of coronary heart disease were randomized in a single centre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::27c05dd50e50a875b38724ae47757474
https://europepmc.org/articles/PMC2042695/
https://europepmc.org/articles/PMC2042695/
Autor:
Bulbulia, R, Bowman, L, Wallendszus, K, Parish, S, Armitage, J, Peto, R, Collins, R, Sandercock, Peter
Publikováno v:
Scopus-Elsevier
Bulbulia, R, Bowman, L, Wallendszus, K, Parish, S, Armitage, J, Peto, R, Collins, R & Sandercock, P 2011, ' Effects on 11-year mortality and morbidity of lowering LDL cholesterol with simvastatin for about 5 years in 20,536 high-risk individuals : a randomised controlled trial ', The Lancet, vol. 378, no. 9808, pp. 2013-20 . https://doi.org/10.1016/S0140-6736(11)61125-2
Lancet
Europe PubMed Central
Bulbulia, R, Bowman, L, Wallendszus, K, Parish, S, Armitage, J, Peto, R, Collins, R & Sandercock, P 2011, ' Effects on 11-year mortality and morbidity of lowering LDL cholesterol with simvastatin for about 5 years in 20,536 high-risk individuals : a randomised controlled trial ', The Lancet, vol. 378, no. 9808, pp. 2013-20 . https://doi.org/10.1016/S0140-6736(11)61125-2
Lancet
Europe PubMed Central
BACKGROUND: Findings of large randomised trials have shown that lowering LDL cholesterol with statins reduces vascular morbidity and mortality rapidly, but limited evidence exists about the long-term efficacy and safety of statin treatment. The aim o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3264bd31b3f4affbd3fc7ae1c5bb739c
http://www.scopus.com/inward/record.url?eid=2-s2.0-84862131858&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-84862131858&partnerID=MN8TOARS